Sen. Bill Nelson Backs Off on Drug Ads

Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.

NEW YORK U.S. Sen. Bill Nelson, D-Fla., a key member of the Senate Finance Committee, has backed off from proposing an amendment to eliminate federal tax deductions for pharmaceutical advertising, sources said.

In a letter to the St. Petersburg Times published on Sept. 11, Nelson, widely considered Florida’s most powerful Democrat in Washington, wrote: “I still intend to offer several significant amendments to the [healthcare] legislation, which, among other things, will help pay for the improvements and expansion of healthcare reforms.

AW+

WORK SMARTER - LEARN, GROW AND BE INSPIRED.

Subscribe today!

To Read the Full Story Become an Adweek+ Subscriber

View Subscription Options

Already a member? Sign in